Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data

Detalles Bibliográficos
Autores principales: Ravelli, A, Brunner, HI, Ruperto, N, Quartier, P, Consolaro, A, Wulffraat, N, Lheritier, K, Gaillez, C, Martini, A, Lovell, DJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184287/
http://dx.doi.org/10.1186/1546-0096-12-S1-P63
_version_ 1782337819411218432
author Ravelli, A
Brunner, HI
Ruperto, N
Quartier, P
Consolaro, A
Wulffraat, N
Lheritier, K
Gaillez, C
Martini, A
Lovell, DJ
author_facet Ravelli, A
Brunner, HI
Ruperto, N
Quartier, P
Consolaro, A
Wulffraat, N
Lheritier, K
Gaillez, C
Martini, A
Lovell, DJ
author_sort Ravelli, A
collection PubMed
description
format Online
Article
Text
id pubmed-4184287
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41842872014-10-30 Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data Ravelli, A Brunner, HI Ruperto, N Quartier, P Consolaro, A Wulffraat, N Lheritier, K Gaillez, C Martini, A Lovell, DJ Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184287/ http://dx.doi.org/10.1186/1546-0096-12-S1-P63 Text en Copyright © 2014 Ravelli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Ravelli, A
Brunner, HI
Ruperto, N
Quartier, P
Consolaro, A
Wulffraat, N
Lheritier, K
Gaillez, C
Martini, A
Lovell, DJ
Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title_full Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title_fullStr Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title_full_unstemmed Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title_short Use of the JADAS criteria to assess efficacy of canakinumab in patients with SJIA – an analysis of 12-week pooled data
title_sort use of the jadas criteria to assess efficacy of canakinumab in patients with sjia – an analysis of 12-week pooled data
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184287/
http://dx.doi.org/10.1186/1546-0096-12-S1-P63
work_keys_str_mv AT ravellia useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT brunnerhi useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT ruperton useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT quartierp useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT consolaroa useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT wulffraatn useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT lheritierk useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT gaillezc useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT martinia useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata
AT lovelldj useofthejadascriteriatoassessefficacyofcanakinumabinpatientswithsjiaananalysisof12weekpooleddata

Ejemplares similares